SCHEDULE 13G/A: Woodline Partners LP Discloses 2.4% Passive Stake in Travere Therapeutics
Beneficial Ownership Disclosure
Woodline Partners LP, an investment adviser, has disclosed a 2.4% passive beneficial ownership stake in Travere Therapeutics, Inc. as of December 31, 2024.
Summary
- Woodline Partners LP, a Delaware limited partnership and investment adviser, reported beneficial ownership of 2,114,056 shares of Travere Therapeutics, Inc. common stock.
- This ownership represents 2.4% of Travere Therapeutics, Inc.'s total outstanding common stock.
- The shares are held by Woodline Master Fund LP, for which Woodline Partners LP serves as the investment adviser.
- Woodline Partners LP maintains sole voting power and sole dispositive power over all 2,114,056 shares.
- This filing is an Amendment No. 1 to a Schedule 13G, indicating a passive investment intent, not for the purpose of changing or influencing control of the issuer.
- The reported percentage is calculated based on an aggregate of 86,893,417 shares of common stock outstanding, which includes the effects of Travere Therapeutics' public offering and the full exercise of underwriters' over-allotment option, as detailed in the company's Prospectus Supplement filed on November 8, 2024.
Sentiment
Score: 5
Explanation: Neutral. This is a standard regulatory filing disclosing passive ownership, providing factual information without expressing positive or negative sentiment about the issuer's performance or outlook.
Future Outlook
NA
Industry Context
NA
Key Dates
| Date | Description |
|---|---|
| 2024-11-08 | Date of filing of Travere Therapeutics' Prospectus Supplement with the SEC, detailing the public offering and over-allotment option exercise. |
| 2024-12-31 | Date of event which requires the filing of this Schedule 13G (reporting period end date). |
| 2025-02-14 | Date of signing and filing of this Schedule 13G Amendment No. 1 by Woodline Partners LP. |
Keywords
Travere Therapeutics, Woodline Partners, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing, Passive Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.